Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infectious plasmid resistance and efflux pump mediated resistance.

J Molnár1, Annamária Molnár, Gabriella Spengler

  • 1Department of Medical Microbiology and Immunobiology, Faculty of General Medicine, University of Szeged, Dóm tér 10, H-6720 Szeged, Hungary. molnarj@comser.szote.u-szeged.hu

Acta Microbiologica Et Immunologica Hungarica
|December 2, 2004
PubMed
Summary

Non-mutagenic heterocyclic compounds can eliminate bacterial plasmids by inhibiting replication and transfer. This offers a mutation-free method for isolating plasmid-free bacteria and a potential strategy to combat antibiotic resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis, molecular modelling and evaluation of (-)-isopulegol-based 2,4-diaminopyrimidines as promising aurora kinase inhibitors.

RSC medicinal chemistry·2026
Same author

Organometallic Complexes with an Indolo[2,3-<i>c</i>]Quinoline-Derived Ligand: From Structural Features and Solution Speciation to Nanoformulation for Enhanced Therapeutic Potential.

Inorganic chemistry·2026
Same author

Evaluation of Novel Benzo-Annelated 1,4-Dihydropyridines as Potential Inhibitors of Antibacterial Efflux Pumps in <i>S. aureus</i> and MRSA Strains.

International journal of molecular sciences·2026
Same author

Self-assembled polymeric prodrug provides controlled cisplatin release and enhanced efficiency in local chemotherapy.

Journal of pharmaceutical sciences·2026
Same author

Flavonoid Oxime Carbamate Derivatives: Reversal of Multidrug Resistance in Cancer Cells.

ChemMedChem·2026
Same author

Overcoming Multidrug Resistance by Bacterial Efflux Pump Inhibitors in Clinical <i>Escherichia coli</i> Strains.

Antibiotics (Basel, Switzerland)·2026

Area of Science:

  • Microbiology
  • Bacteriology
  • Molecular Biology

Background:

  • Bacterial plasmids, particularly those encoding antibiotic resistance, pose significant challenges in clinical and biotechnological settings.
  • Plasmid elimination is a desirable goal for both therapeutic and industrial applications.

Purpose of the Study:

  • To investigate the efficacy of non-mutagenic heterocyclic compounds in eliminating bacterial plasmids.
  • To elucidate the mechanisms of antiplasmid action at the molecular level.
  • To explore the potential applications of plasmid elimination in biotechnology and combating antibiotic resistance.

Main Methods:

  • Treatment of bacterial cultures (pure and mixed) with various heterocyclic compounds at subinhibitory concentrations.
  • Analysis of compound effects on plasmid DNA replication, partition, and conjugal transfer.

Related Experiment Videos

  • Investigation of drug-binding interactions with different forms of plasmid DNA.

    • Main Results:

    • Heterocyclic compounds effectively eliminate plasmids by simultaneously inhibiting intracellular replication, partition, and intercellular transfer.
    • The antiplasmid activity is dependent on the chemical structure of the compounds.
    • Superhelical plasmid DNA binds more drug molecules than linear or open-circular forms, leading to functional inactivation.
    • Complete plasmid elimination from all cells in complex ecosystems remains a challenge.

    Conclusions:

    • Non-mutagenic heterocyclic compounds provide a novel approach for plasmid elimination without inducing mutations, valuable for biotechnology.
    • Targeting plasmid replication and transfer mechanisms offers a new avenue for rational drug design against bacterial plasmids.
    • Inhibition of antibiotic resistance plasmid transfer can reduce their spread in bacterial populations.